$RKLB

Rocket Lab delays Neutron's first flight to 2027 due to a defect in the first propellant tank's forward dome, according to Spaceflight Now. CEO Peter Beck outlined a three-step process to address the issue, with completion expected by Q1 2027.

Rocket Lab's shares dropped 7.3% in extended trading after the company delayed the first launch of its Neutron rocket to 2027, citing manufacturing issues with a carbon-composite component. The delay impacts the company's timeline and investor expectations.

Rocket Lab Corp (RKLB) filed an SEC Form 8-K — Other Events. MEDIA RELEASE Exhibit 99.1 Rocket Lab Provides Update on Neutron Development and Adjusts Target Launch Timing LONG BEACH, Calif., Oct. 14, 2026 – Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today sha

Rocket Lab (RKLB) shares have fallen 57% from their May high, but ARK Invest has purchased 1.3 million shares since August, betting on Rocket Lab's Neutron rocket and launch capacity demand. The company's backlog reached $2.36 billion, but cash burn concerns and valuation at 42 times sales raise risks. Analysts give RKLB a Strong Buy rating with a $104.44 price target.

CIBC plans to list 11 new U.S. Canadian Depositary Receipts (CDRs) on the TSX, starting October 20, 2026, expanding its offering to 144 CDRs. These CDRs represent well-known U.S. companies and provide Canadian investors with access to global stocks in Canadian dollars, with a built-in currency hedge. The new CDRs include companies like Bloom Energy, Bristol-Myers Squibb, and Snowflake.

Rocket Lab (RKLB) shares rose 1% overnight after announcing 12 hypersonic test launches this year, supporting U.S. weapons development. The company's HASTE vehicle offers low-cost, high-frequency testing. RKLB stock fell 2% to $64.22 on Tuesday, down 8% year-to-date. Recent contracts include a $190M deal for 20 flights and a $266M Space Force contract.

Rocket Lab CFO Adam Spice sold 140,157 shares worth $9.9M after exercising options. Shares were sold at $69.53-$72.39 each, with exercise cost of $152,771. Trades were under a 10b5-1 plan. Spice holds 1.16M shares directly, 250,000 via trust, and 2.24M options. Shares traded at $65.71 premarket, down 12.5% from prior week.

Rocket Lab (RKLB) faces uncertainty as investors await the debut of its Neutron rocket. The stock has fallen 56% since May. Top investor JR Research downgraded RKLB to Hold, citing lack of proof for Neutron's success and competitive pressure from SpaceX. Electron business growth and Iridium acquisition provide stability, but Neutron is key for long-term potential. RKLB trades at 34x forward revenue, with a Strong Buy consensus and 64% upside target.

The global space launch services market is projected to grow to $29.6B by 2027, driven by demand for payload launches. Starfighters Space (FJET) plans a December captive-carry flight for its STARLAUNCH™ 1 program, aiming to test air-launch capabilities. Other companies like Rocket Lab (RKLB), Karman (KRMN), Voyager (VOYG), and Redwire (RDW) reported record revenues and backlogs, indicating strong sector growth.

Rocket Lab (RKLB) launched its 18th rocket of 2026, including 13 for Synspective, with 34 more launches under contract. The company aims for 27 launches this year, up from 21 in 2025. Additionally, Rocket Lab's $8B acquisition of Iridium Communications (IRDM) was approved by Iridium shareholders, pending regulatory approval. The deal is expected to make Rocket Lab profitable and free cash flow positive by mid-2027.